search
Back to results

Phrenic Nerve Infiltration in Neck Pain (PAINOMICS)

Primary Purpose

Chronic Neck Pain

Status
Recruiting
Phase
Phase 4
Locations
Spain
Study Type
Interventional
Intervention
Bupivacaine
Placebo (physiological saline serum infiltration)
Sponsored by
University of Seville
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Chronic Neck Pain focused on measuring phrenic nerve, anesthesia, local

Eligibility Criteria

18 Years - 64 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Over 18 and under 64 years old Patients attending to the physician or physical therapist with a main complaint of neck pain Presentation of any peridiaphragmatic visceral disorder. That the subject agrees to participate in the project by signing the informed consent. Exclusion Criteria: Illness of neurological, traumatic, oncological, infectious or rheumatic (fibromyalgia, ankylosing spondylitis...) origin. Uncooperative subject. Severe psychiatric illness. Loss of Cognitive Ability. Contraindication to infiltration of the phrenic nerve. History of head, spinal or upper limb surgery History of infiltration for the neck pain in the previous 3 months History of physical therapy for the neck pain in the previous 30 days

Sites / Locations

  • Nacho Navarro FisioterapiaRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Phrenic nerve anesthetics infiltration

Physiological serum infiltration

Arm Description

The experimental intervention will consist of ultrasound-guided anesthetic blockade of the phrenic nerve at the laterocervical supraclavicular level with 1 ml of lidocaine without vasoconstrictor 2% to infiltrate the skin and 3ml of bupivacaine without vasoconstrictor 0.25% for neural blockade, making the local anesthetic surround the nerve between the anterior scalene muscle and the sternocleidomastoid muscle.

The placebo intervention will be similar in relation to 2% lidocaine without vasoconstrictor for the skin, but an ultrasound-guided puncture will be performed at the level of the subcutaneous cellular tissue by injecting 3 ml of physiological saline.

Outcomes

Primary Outcome Measures

Change from baseline in algometry
Pressure pain threshold in neck tissues. PPT levels defined as the minimum necessary pressure to evoke pain will be evaluated using a handheld electronic pressure algometer.

Secondary Outcome Measures

Range of motion
Neck range of motion.The range of motion will be assessed in degrees. Flexion, extension, left and right side flexion, and left and right rotation will be assessed, and the sum of all of those parameters will be the considered outcome.
Visual Analogue Scale
Perceived neck pain. Self-perceived pain intensity will be evaluated during all active cervical movements by a 0 to 10 Visual Analogue Scale (VAS), where 0 denotes no pain and 10 denotes the maximum possible pain.
Neck Disability Index
Neck Disability Index (Questionnaire). The Neck Disability Index will be used in the Spanish version. This questionnaire assesses how neck pain affects the ability to manage everyday-life activities. Scores range from 0-50 with higher scores indicating higher disability.
Headache Impact Test-6
Headache Impact Test (Questionnaire). The Headache Impact Test-6 was developed to measure a wide spectrum of the factors contributing to the burden of headache, and it has demonstrated utility for generating quantitative and pertinent information on the impact of headache. Scores range from 0-120 with higher scores indicating a worse outcome.

Full Information

First Posted
October 23, 2022
Last Updated
May 8, 2023
Sponsor
University of Seville
search

1. Study Identification

Unique Protocol Identification Number
NCT05605639
Brief Title
Phrenic Nerve Infiltration in Neck Pain
Acronym
PAINOMICS
Official Title
Phrenic Afferences In Organic and Metabolic Illness: Central Sensitization
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 17, 2022 (Actual)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
November 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Seville

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No

5. Study Description

Brief Summary
Neck pain frequently present comorbidities in peridiaphragmatic organs. The innervation of these organs include the phrenic nerve. It is known that peridiaphragmatic organs trigger referred pain in the neck area. As well, previous studies have shown that visceral disorders increase sensitization in somatic tissues. This study aims to analyze the ability of phrenic nerve infiltration to diminish sensitization and improve neck symptoms in the absence of neurological, traumatic or infectious pathology that justifies the pain, by means of a randomized controlled trial.
Detailed Description
Pain is a major problem due to issues such as the impact on quality of life and the associated health and social costs. Neck pain is a very common disorder in our society. It is characterized by the presence of hyperalgesia, increased muscle tone, limited range of motion and sensitization. It is well known that pain of visceral origin can generate all these phenomena. In most cases, there is no antecedent of trauma, and no evidence of a specific origin (oncologic, rheumatic, infectious…), so patients are classified as suffering non-specific or idiopathic pain. The absence of a specific diagnosis makes it difficult to find a therapeutic target to increase the probability of successful therapies. Thus, in the case of neck pain, the recurrence of consultations is very high. It is known that cervical pain frequently presents peridiaphragmatic visceral comorbidities. Furthermore, it is known that these peridiaphragmatic organs produce referred pain to the neck, and this pain is known as phrenic pain. To date, there are no studies that analyze the role of phrenic afferents in subjects with neck pain and peridiaphragmatic visceral disorders. The aim of this study is to evaluate the effect of phrenic nerve anaesthesia in subjects with neck pain. For this purpose, the investigators intend to perform a randomised clinical trial, assessing the effects on pain threshold to pressure, visual analogue scale, range of motion and craniocervical questionnaires. There will be only one intervention session. The experimental group will receive an ultrasound-guided anaesthetic infiltration of the phrenic nerve, while the control group will receive a placebo infiltration. A one-week follow-up, with intermediate measurements, will be carried out to assess the evolution of cervical sensitization and symptomatology. The results of this study will make it possible to establish the role of peridiaphragmatic organic disorders and phrenic afferents in cervical pain, thus making it possible to specify a specific therapeutic target (phrenic nerve) as well as the importance of visceral treatment in subjects presenting for consultation for cervical pain.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Chronic Neck Pain
Keywords
phrenic nerve, anesthesia, local

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Phrenic nerve anesthetics infiltration
Arm Type
Experimental
Arm Description
The experimental intervention will consist of ultrasound-guided anesthetic blockade of the phrenic nerve at the laterocervical supraclavicular level with 1 ml of lidocaine without vasoconstrictor 2% to infiltrate the skin and 3ml of bupivacaine without vasoconstrictor 0.25% for neural blockade, making the local anesthetic surround the nerve between the anterior scalene muscle and the sternocleidomastoid muscle.
Arm Title
Physiological serum infiltration
Arm Type
Placebo Comparator
Arm Description
The placebo intervention will be similar in relation to 2% lidocaine without vasoconstrictor for the skin, but an ultrasound-guided puncture will be performed at the level of the subcutaneous cellular tissue by injecting 3 ml of physiological saline.
Intervention Type
Drug
Intervention Name(s)
Bupivacaine
Other Intervention Name(s)
Bupivacaine B. Braun 2.5 mg/ml
Intervention Description
The experimental intervention will consist of ultrasound-guided anesthetic blockade of the phrenic nerve at the laterocervical supraclavicular level with 1 ml of lidocaine without vasoconstrictor 2% to infiltrate the skin and 3ml of bupivacaine without vasoconstrictor 0.25% for neural blockade, making the local anesthetic surround the nerve between the anterior scalene muscle and the sternocleidomastoid muscle.
Intervention Type
Other
Intervention Name(s)
Placebo (physiological saline serum infiltration)
Intervention Description
The placebo intervention will be similar in relation to 2% lidocaine without vasoconstrictor for the skin, but an ultrasound-guided puncture will be performed at the level of the subcutaneous cellular tissue by injecting 3 ml of physiological saline.
Primary Outcome Measure Information:
Title
Change from baseline in algometry
Description
Pressure pain threshold in neck tissues. PPT levels defined as the minimum necessary pressure to evoke pain will be evaluated using a handheld electronic pressure algometer.
Time Frame
Pre-intervention. Post-intervention: 1 hour, 2 hours, 3 days and 7 days
Secondary Outcome Measure Information:
Title
Range of motion
Description
Neck range of motion.The range of motion will be assessed in degrees. Flexion, extension, left and right side flexion, and left and right rotation will be assessed, and the sum of all of those parameters will be the considered outcome.
Time Frame
Pre-intervention. Post-intervention: 1 hour, 2 hours, 3 days and 7 days
Title
Visual Analogue Scale
Description
Perceived neck pain. Self-perceived pain intensity will be evaluated during all active cervical movements by a 0 to 10 Visual Analogue Scale (VAS), where 0 denotes no pain and 10 denotes the maximum possible pain.
Time Frame
Pre-intervention. Post-intervention: 1 hour, 2 hours, 3 hours, 6 hours, 24 hours, 2 days, 3 days and 7 days
Title
Neck Disability Index
Description
Neck Disability Index (Questionnaire). The Neck Disability Index will be used in the Spanish version. This questionnaire assesses how neck pain affects the ability to manage everyday-life activities. Scores range from 0-50 with higher scores indicating higher disability.
Time Frame
Pre-intervention. Post-Intervention: 3 days and 7 days.
Title
Headache Impact Test-6
Description
Headache Impact Test (Questionnaire). The Headache Impact Test-6 was developed to measure a wide spectrum of the factors contributing to the burden of headache, and it has demonstrated utility for generating quantitative and pertinent information on the impact of headache. Scores range from 0-120 with higher scores indicating a worse outcome.
Time Frame
Pre-intervention. Post-intervention: 3 days and 7 days.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Over 18 and under 64 years old Patients attending to the physician or physical therapist with a main complaint of neck pain Presentation of any peridiaphragmatic visceral disorder. That the subject agrees to participate in the project by signing the informed consent. Exclusion Criteria: Illness of neurological, traumatic, oncological, infectious or rheumatic (fibromyalgia, ankylosing spondylitis...) origin. Uncooperative subject. Severe psychiatric illness. Loss of Cognitive Ability. Contraindication to infiltration of the phrenic nerve. History of head, spinal or upper limb surgery History of infiltration for the neck pain in the previous 3 months History of physical therapy for the neck pain in the previous 30 days
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Angel Oliva Pascual-Vaca, Dr
Phone
0034 954486524
Email
angeloliva@us.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Angel Oliva Pascual-Vaca, Dr
Organizational Affiliation
University of Seville
Official's Role
Principal Investigator
Facility Information:
Facility Name
Nacho Navarro Fisioterapia
City
Dos Hermanas
State/Province
Seville
ZIP/Postal Code
41089
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Ignacio Navarro Carmona, MSc
Phone
0034 689712976

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Phrenic Nerve Infiltration in Neck Pain

We'll reach out to this number within 24 hrs